News
-
Important update for Health Technology Assessments in Norway
From September 1st, companies must notify the Norwegian Medical Products Agency (NoMA) at least three months prior to submitting documentation for assessment. Early notification will help NoMA recruit medical experts and plan resources efficiently — ensuring the assessment process can start immediately once documentation is received. 👉 If your company is involved in HTAs in […]
-
-
Patient Safety First: Why Human Quality Control Is Essential
In a time when artificial intelligence (AI) and automated systems are playing an increasingly prominent role in the healthcare and pharmaceutical industries, it's easy to be impressed by how quickly and efficiently technology can produce content. But there is one thing AI can never replace: professional judgment.
-
The Norwegian Drug Liability Association: Mandatory Insurance for Pharmaceutical Companies
In Norway, strict regulations govern the safety and responsibility associated with the manufacturing, import, and testing of medicinal products. To ensure that patients affected by drug-related injuries receive compensation, all stakeholders in this sector are required to obtain insurance through the Norwegian Drug Liability Association (DLA). This insurance is a legal requirement under Chapter 3 of the Norwegian Product Liability Act.
-
Ensuring Pharmaceutical Quality: WHO Certificate and Apostille
In the pharmaceutical sector, it is crucial to ensure that medicinal products meet strict quality, safety, and efficacy requirements. This is not only essential for patient safety but also for obtaining approval in various markets. Two key requirements for the international distribution of pharmaceuticals are the WHO Certificate (Certificate of Pharmaceutical Product – CPP) and the apostille stamp.
-
A new chapter has started
Today, we celebrated Gun Wikman as she heads into a well-deserved retirement. It’s with gratitude, a bit of nostalgia, and a lot of smiles that we say thank you for everything you’ve brought to Mericon.